The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Athiya Agarwal, a promoter of Dr. Agarwals Health Care Ltd, has informed the stock exchanges about a proposed acquisition of 21,15,180 shares (0.67% of share capital) from Dr. Anosh Agarwal, another promoter and immediate relative. The transfer is scheduled for March 3, 2026, and is being done as a gift with no consideration involved. As a result, Dr. Athiya Agarwal's holding will rise from 3.33% to 4.00%, while Dr. Anosh Agarwal's holding will fall from 5.36% to 4.69%. The total promoter and promoter group shareholding in the company remains unchanged, as this is only a reshuffle of shares within the promoter family.
This is a routine internal family arrangement and has no impact on the company's total promoter shareholding or on public shareholders. No money is involved and no open offer is triggered, so there is no material effect on the stock price.